BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Zhang J, Zhou Y, Jiang K, Shen Z, Ye Y, Wang S. Evaluation of the seventh AJCC TNM staging system for gastric cancer: a meta-analysis of cohort studies. Tumour Biol 2014;35:8525-32. [PMID: 24696259 DOI: 10.1007/s13277-014-1848-6] [Cited by in Crossref: 21] [Cited by in F6Publishing: 21] [Article Influence: 2.6] [Reference Citation Analysis]
Number Citing Articles
1 Guo J, Xu A, Sun X, Zhao X, Xia Y, Rao H, Zhang Y, Zhang R, Chen L, Zhang T, Li G, Xu H, Xu D. Three-year outcomes of the randomized phase III SEIPLUS trial of extensive intraoperative peritoneal lavage for locally advanced gastric cancer. Nat Commun 2021;12:6598. [PMID: 34782599 DOI: 10.1038/s41467-021-26778-8] [Reference Citation Analysis]
2 Huang Y, Huang Y, Wang H, Zhang H, Shi L, Li C, Li X, Zeng Y, Liu Y, Wu M, Wang J, Wang J. The effect of low molecular weight-polycyclic aromatic hydrocarbons responsive hsa_circ_0039929/hsa-miR-15b-3p_R-1/FGF2 circuit on inflammatory response of A549 cells via the PI3K/AKT pathway and epithelial-mesenchymal transition process. Environ Toxicol 2022. [PMID: 35475590 DOI: 10.1002/tox.23546] [Reference Citation Analysis]
3 Liu S, Zheng H, Zhang Y, Chen L, Guan W, Guan Y, Ge Y, He J, Zhou Z. Whole-volume apparent diffusion coefficient-based entropy parameters for assessment of gastric cancer aggressiveness. J Magn Reson Imaging. 2018;47:168-175. [PMID: 28471511 DOI: 10.1002/jmri.25752] [Cited by in Crossref: 19] [Cited by in F6Publishing: 23] [Article Influence: 3.8] [Reference Citation Analysis]
4 Kim G, Chen E, Tay AY, Lee JS, Phua JN, Shabbir A, So JB, Tai BC. Extensive peritoneal lavage after curative gastrectomy for gastric cancer (EXPEL): study protocol of an international multicentre randomised controlled trial. Jpn J Clin Oncol 2017;47:179-84. [PMID: 28173154 DOI: 10.1093/jjco/hyw153] [Cited by in Crossref: 12] [Cited by in F6Publishing: 8] [Article Influence: 2.4] [Reference Citation Analysis]
5 Liu J, Xu H, Wang N, Sun M. miR-15b, a diagnostic biomarker and therapeutic target, inhibits oesophageal cancer progression by regulating the PI3K/AKT signalling pathway. Exp Ther Med. 2020;20:222. [PMID: 33363587 DOI: 10.3892/etm.2020.9352] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
6 Liu HT, Wang YW, Xing AY, Shi DB, Zhang H, Guo XY, Xu J, Gao P. Prognostic Value of microRNA Signature in Patients with Gastric Cancers. Sci Rep 2017;7:42806. [PMID: 28202938 DOI: 10.1038/srep42806] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 1.6] [Reference Citation Analysis]
7 Tang X, Lan Z, Chen Y, Zhang J, Che X, Wang C. The 7th AJCC/UICC TNM staging system may be not suitable in predicting prognosis of synchronous multiple gastric carcinoma patients with D2 gastrectomy. Tumour Biol 2015;36:3653-9. [PMID: 25566962 DOI: 10.1007/s13277-014-3003-9] [Reference Citation Analysis]
8 Li P, He HQ, Zhu CM, Ling YH, Hu WM, Zhang XK, Luo RZ, Yun JP, Xie D, Li YF, Cai MY. The prognostic significance of lymphovascular invasion in patients with resectable gastric cancer: a large retrospective study from Southern China. BMC Cancer 2015;15:370. [PMID: 25947284 DOI: 10.1186/s12885-015-1370-2] [Cited by in Crossref: 24] [Cited by in F6Publishing: 31] [Article Influence: 3.4] [Reference Citation Analysis]
9 Tang X, He Q, Sun G, Qu H, Liu J, Gao L, Shi J, Ye J, Liang Y. Total Tumor Volume Should be Considered as an Important Prognostic Factor for Synchronous Multiple Gastric Cancer Patients with Curative Gastrectomy. Pathol Oncol Res 2020;26:2169-75. [PMID: 32170582 DOI: 10.1007/s12253-020-00804-4] [Reference Citation Analysis]
10 Mocellin S, Nitti D. Lymphadenectomy extent and survival of patients with gastric carcinoma: a systematic review and meta-analysis of time-to-event data from randomized trials. Cancer Treat Rev 2015;41:448-54. [PMID: 25814393 DOI: 10.1016/j.ctrv.2015.03.003] [Cited by in Crossref: 24] [Cited by in F6Publishing: 22] [Article Influence: 3.4] [Reference Citation Analysis]
11 Imamura T, Komatsu S, Ichikawa D, Kosuga T, Okamoto K, Konishi H, Shiozaki A, Fujiwara H, Otsuji E. Clinical characteristics of hepatoduodenal lymph node metastasis in gastric cancer. World J Gastroenterol 2015; 21(38): 10866-10873 [PMID: 26478677 DOI: 10.3748/wjg.v21.i38.10866] [Cited by in CrossRef: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
12 Yang HK, Ji J, Han SU, Terashima M, Li G, Kim HH, Law S, Shabbir A, Song KY, Hyung WJ, Kosai NR, Kono K, Misawa K, Yabusaki H, Kinoshita T, Lau PC, Kim YW, Rao JR, Ng E, Yamada T, Yoshida K, Park DJ, Tai BC, So JBY; EXPEL study group. Extensive peritoneal lavage with saline after curative gastrectomy for gastric cancer (EXPEL): a multicentre randomised controlled trial. Lancet Gastroenterol Hepatol 2021;6:120-7. [PMID: 33253659 DOI: 10.1016/S2468-1253(20)30315-0] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
13 Lei G, Yang H, Hong T, Zhou C, Li J, Liu W, Hu J, Zeng L, Chen G, Chen Q, Zhang Y, Yang N. Elastic staining-a rejuvenated method to reassess prognosis and serosal invasion in patients with pT3N0M0 gastric cancer. Hum Pathol 2017;65:79-84. [PMID: 28504204 DOI: 10.1016/j.humpath.2017.04.023] [Reference Citation Analysis]
14 Oh SJ, Suh BJ, Park JK, Oh SD, Yu HJ. Prognostic Discrepancy of the 6th and 7th UICC N Classification for Lymph Node Staging in Gastric Cancer Patients after Curative Resection. Case Rep Oncol 2017;10:57-65. [PMID: 28203165 DOI: 10.1159/000455189] [Cited by in Crossref: 4] [Article Influence: 0.8] [Reference Citation Analysis]
15 Kwon OK, Kim SW, Chae HD, Ryu SW, Chung HY, Kim SW, Lee WK, Yu W. Validation of the 7th AJCC/UICC staging system for gastric cancer and a proposal for a new TNM system based on a prognostic score: a retrospective multicenter study. Ann Surg Treat Res 2016;91:295-302. [PMID: 27904851 DOI: 10.4174/astr.2016.91.6.295] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 1.2] [Reference Citation Analysis]
16 Huang T, Wang L, Liu D, Li P, Xiong H, Zhuang L, Sun L, Yuan X, Qiu H. FGF7/FGFR2 signal promotes invasion and migration in human gastric cancer through upregulation of thrombospondin-1. Int J Oncol 2017;50:1501-12. [PMID: 28339036 DOI: 10.3892/ijo.2017.3927] [Cited by in Crossref: 46] [Cited by in F6Publishing: 47] [Article Influence: 9.2] [Reference Citation Analysis]
17 Yaprak G, Tataroglu D, Dogan B, Pekyurek M. Prognostic factors for survival in patients with gastric cancer: Single-centre experience. North Clin Istanb 2020;7:146-52. [PMID: 32259036 DOI: 10.14744/nci.2019.73549] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
18 Han C, Xu T, Zhang Q, Liu J, Ding Z, Hou X. The New American Joint Committee on Cancer T staging system for stomach: increased complexity without clear improvement in predictive accuracy for endoscopic ultrasound. BMC Gastroenterol 2021;21:255. [PMID: 34116629 DOI: 10.1186/s12876-020-01558-8] [Reference Citation Analysis]
19 Mahar AL, Zagorski B, Kagedan D, Dixon M, El-Sedfy A, Vasilevska-Ristovska J, Cortinovis D, Rowsell C, Law C, Helyer L, Paszat L, Coburn N. Evaluating TNM stage prognostic ability in a population-based cohort of gastric adenocarcinoma patients in a low-incidence country. Can J Public Health 2018;109:480-8. [PMID: 30091108 DOI: 10.17269/s41997-018-0102-1] [Cited by in Crossref: 4] [Cited by in F6Publishing: 6] [Article Influence: 1.0] [Reference Citation Analysis]
20 Orman S, Cayci HM. Gastric cancer: factors affecting survival. Acta Chir Belg 2019;119:24-30. [PMID: 29560799 DOI: 10.1080/00015458.2018.1453437] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 2.3] [Reference Citation Analysis]
21 Kang WM, Meng QB, Yu JC, Ma ZQ, Li ZT. Factors associated with early recurrence after curative surgery for gastric cancer. World J Gastroenterol 2015; 21(19): 5934-5940 [PMID: 26019458 DOI: 10.3748/wjg.v21.i19.5934] [Cited by in CrossRef: 39] [Cited by in F6Publishing: 39] [Article Influence: 5.6] [Reference Citation Analysis]
22 de Mestier L, Lardière-Deguelte S, Volet J, Kianmanesh R, Bouché O. Recent insights in the therapeutic management of patients with gastric cancer. Dig Liver Dis. 2016;48:984-994. [PMID: 27156069 DOI: 10.1016/j.dld.2016.04.010] [Cited by in Crossref: 22] [Cited by in F6Publishing: 23] [Article Influence: 3.7] [Reference Citation Analysis]
23 Shi C, Liu B, Yan J, Liu H, Pan Z, Yao W, Yan F, Zhang H. Gastric Cancer: Preoperative TNM Staging With Individually Adjusted Computed Tomography Scanning Phase. J Comput Assist Tomogr. 2016;40:160-166. [PMID: 26720202 DOI: 10.1097/rct.0000000000000339] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 1.2] [Reference Citation Analysis]
24 Go SI, Lee MJ, Lee WS, Choi HJ, Lee US, Kim RB, Kang MH, Kim HG, Lee GW, Kang JH. D-Dimer Can Serve as a Prognostic and Predictive Biomarker for Metastatic Gastric Cancer Treated by Chemotherapy. Medicine (Baltimore). 2015;94:e951. [PMID: 26222870 DOI: 10.1097/md.0000000000000951] [Cited by in Crossref: 25] [Cited by in F6Publishing: 11] [Article Influence: 3.6] [Reference Citation Analysis]